Long-term follow-up for patients who had a specific glaucoma surgery
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study
This study looks at how well the MIMS® surgery for open-angle glaucoma works over 24 to 30 months by following patients who have already had the procedure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 53 (estimated) |
| Ages | 40 Years to 85 Years |
| Sex | All |
| Sponsor | Sanoculis Ltd Industry-sponsored |
| Locations | 1 site (Yerevan) |
| Trial ID | NCT06577857 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect long-term data from patients who have previously undergone the MIMS® inferonasal procedure for open-angle glaucoma. It will follow participants for 24 to 30 months to assess the outcomes and effectiveness of this minimally invasive surgery. The study is non-interventional and open-label, focusing on the intraocular pressure and overall health of the patients post-surgery.
Who should consider this trial
Good fit: Ideal candidates are individuals who have previously undergone the MIMS® inferonasal procedure at least 24 months prior to enrollment.
Not a fit: Patients who have not had the MIMS® inferonasal procedure or those who had the surgery less than 24 months ago will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness of the MIMS® procedure for managing open-angle glaucoma.
How similar studies have performed: While this study builds on previous investigations of the MIMS® device, the long-term follow-up aspect may provide novel insights into its effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Subject who underwent MIMS® inferonasal procedure, and surgery was performed not earlier than 24 months from enrollment
Where this trial is running
Yerevan
- S. Malayan Eye Center — Yerevan, Armenia (Recruiting)
Study contacts
- Study coordinator: Khan Lau, OD
- Email: khan@sanoculis.com
- Phone: 8082862666
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.